A number of presentations over the past few days have addressed the health economics of SLE. Clarke et al (abstract 2811) studied the costs associated with damage states in a large Canadian lupus cohort as well as in the SL ICC cohort (abstract 2925).
Dr. Ramsey-Goldman is globally recognized for her clinical skills, diversity of her research efforts and focus on lupus. Over the past 30 years, she has worked at the interface between immunology and rheumatology, and has undertaken several major committee assignments for the American College of Rheumatology (ACR), National Institutes of Health (NIH), and the Systemic […]
Dr. M. Urowitz has recieved the American College of Rheumatology’s 2017 Distinguished Clinical Investigator Award. This distinction is awarded to a clinical scientist making outstanding contributions to the field of rheumatology. This award was known as the Clinical Research Award prior to 2006.
Dr. W. Winn Chatham has received the American College of Rheumatology’s 2017 Distinguished Clinician Scholar Award. This distinction is awarded to a rheumatologist who has made outstanding contributions in clinical medicine, clinical scholarship, or education.
The winner of this year’s Hess award is Dafna Gladman, MD, who is a rheumatologist at the Center for Prognosis Studies, Toronto Western Hospital, Toronto Canada. Dr. Gladman is co-director of the University of Toronto Lupus Clinic and has undertaken numerous and wide-ranging studies of the disease including genetic analyses, studies of morbidity and the […]
We are happy to report that many of our participants have been followed for more than 10 years. It is hard to believe this registry began in 2000. Our very first enrolled patient is now at 15 years of follow-up. Achieving our goal of 1800 participants has allowed us to study the long term effects […]
We are happy to report we have reached our recruitment target of 1800 patients. This constitutes the world’s largest cohort of newly diagnosed SLE patients assembled to date! Achieving our goal of 1800 patients has marked the end of the beginning as we are now in the long term follow phase of the study. This […]
Our original goal for the registry was to enroll 1650 patients and follow these patients for a 10 year period. We are happy to report that many of you are just beginning to reach the 10 year follow-up mark. We have now extended our follow up from 10 years to as long as you wish […]
We are pleased to report that we are now close to our new recruitment goal of 1650 participants. As of May 2009, 1408 participants have been enrolled in the Registry. This constitutes the largest cohort of newly diagnosis SLE patients assembled to date!